Why is Titan Biotech falling/rising?

As of 15-Sep, Titan Biotech Ltd's stock price is rising, currently at 815.95, reflecting an increase of 35.25 (4.52%). The stock has been on an upward trend, gaining for the last five days and achieving a remarkable 21.02% return over that period. Today, it opened with a gain of 2.47% and reached an intraday high of Rs 819.7, indicating strong investor interest. The stock is trading above its moving averages across various time frames, and there has been a significant increase in delivery volume, suggesting rising investor participation. Despite a low Debt to Equity ratio and consistent returns over the last three years, concerns remain regarding its long-term growth due to a decline in operating profit and a high Price to Book Value ratio compared to peers. In the broader market context, Titan Biotech's performance has significantly outpaced the benchmark Sensex, which only gained 1.24% over the past week. The stock's year-to-date return of 11.35% also surpasses the Sensex's 4.67%, showcasing its strong relative performance. However, the stock's premium valuation and the lack of domestic mutual fund investment may indicate caution among institutional investors, which could affect future price movements. Overall, while the stock is currently rising, the mixed signals regarding its long-term growth potential and valuation suggest that investors should remain vigilant.